Rafarma Pharmaceuticals, Inc. (RAFA)

OTCMKTS · Delayed Price · Currency is USD

0.02352

-0.00848 (-26.50%)

At close: Oct 7, 2026

Rafarma Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2012	FY 2011
Period Ending	Mar '12 Mar 31, 2012	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011
Revenue	0.13	0.13	0.13
Revenue Growth	-	0%	-
Operating Income	-0.11	-0.11	-0.11
Net Income	-0.12	-0.12	-0.12
Earnings Per Share	-0.01	-0.01	-0.01
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2012	FY 2011
Period Ending	Mar '12 Mar 31, 2012	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011
Cash & Investments	0.12	0.12	0.09
Total Debt	0.24	0.24	0.23
Net Cash (Debt)	-0.12	-0.12	-0.14
Net Cash Growth	-	-	-
Net Cash Per Share	-0.02	-0.02	-0.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2012	FY 2011
Period Ending	Mar '12 Mar 31, 2012	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011
Operating Cash Flow	0.03	0.03	0.03
Free Cash Flow	0.03	0.03	0.03
Free Cash Flow Growth	-	0%	-

Margins

Fiscal Year	TTM	FY 2012	FY 2011
Period Ending	Mar '12 Mar 31, 2012	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011
Operating Margin	-81.25%	-81.25%	-81.25%
Pretax Margin	-87.92%	-87.92%	-87.92%
Profit Margin	-87.92%	-87.92%	-87.92%